首页> 外国专利> USES OF PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) INHIBITORS

USES OF PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) INHIBITORS

机译:纤溶酶原激活物抑制剂1(PAI-1)抑制剂的用途

摘要

The present disclosures provides surprising insight into new technologies for treatment and/or prevention of certain types of hair loss (also known as alopecia), including androgenetic alopecia, alopecia areata, frontal fibrosing alopecia, and senescent alopecia. Among other things, the present disclosure provides surprising insight that plasminogen activator inhibitor -1 (PAI-1) inhibitors may be surprisingly effective and/or useful in the treatment and/or prevention of certain types of hair loss, including androgenetic alopecia, alopecia areata, frontal fibrosing alopecia, and senescent alopecia. Furthermore, the present disclosure provides insight that provided new technologies may not be particularly effective and/or useful in the treatment and/or prevention of other types of alopecia such as radiation-induced alopecia, chemotherapy-induced alopecia, and alopecia due to chronic discoid lupus erythematosus.
机译:本揭露为治疗和/或预防某些类型的脱发(也称为脱发)提供了令人惊讶的洞察力,包括雄激素脱发,脱发脱发,椎体抗刺激性脱发和衰老脱发。除此之外,本公开提供了令人惊讶的识别识理,即纤溶酶原激活剂抑制剂-1(PAI-1)抑制剂可能令人惊讶的是有效的和/或可用于治疗和/或预防某些类型的脱发,包括嗜血体脱发,Alopecia Areata ,正面造型脱发和衰老脱发。此外,本公开提供了洞察力,即提供的新技术可能在治疗和/或预防其他类型的脱发和/或预防诸如辐射诱导的脱发,化学疗法诱导的脱发,由于慢性含量的辐射诱导的脱发和血症症状红斑狼疮。

著录项

  • 公开/公告号EP3849540A1

    专利类型

  • 公开/公告日2021-07-21

    原文格式PDF

  • 申请/专利权人 EIRION THERAPEUTICS INC.;

    申请/专利号EP20190779255

  • 发明设计人 EDELSON JONATHAN;

    申请日2019-09-12

  • 分类号A61K31/341;A61K31/343;A61K31/401;A61K31/4166;A61K45;A61P17/14;

  • 国家 EP

  • 入库时间 2022-08-24 20:02:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号